Sabra Healthcare Financials
SBRA Stock | USD 18.91 0.07 0.37% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 1.28 | 0.8614 |
|
| |||||
Operating Income | 163 M | 218.6 M |
|
| |||||
Current Ratio | 0.87 | 0.9191 |
|
|
The essential information of the day-to-day investment outlook for Sabra Healthcare includes many different criteria found on its balance sheet. An individual investor should monitor Sabra Healthcare's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Sabra Healthcare.
Net Income |
|
Sabra | Select Account or Indicator |
Understanding current and past Sabra Healthcare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sabra Healthcare's financial statements are interrelated, with each one affecting the others. For example, an increase in Sabra Healthcare's assets may result in an increase in income on the income statement.
Please note, the presentation of Sabra Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sabra Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sabra Healthcare's management manipulating its earnings.
Sabra Healthcare Stock Summary
Sabra Healthcare competes with Healthcare Realty, Healthpeak Properties, Community Healthcare, Universal Health, and Global Medical. As of March 31, 2022, Sabras investment portfolio included 416 real estate properties held for investment. As of March 31, 2022, Sabras real estate properties held for investment included 41,445 bedsunits, spread across the United States and Canada. Sabra REIT operates under REITHealthcare Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 42 people.Specialization | Real Estate, Equity Real Estate Investment Trusts (REITs) |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US78573L1061 |
CUSIP | 78573L106 |
Location | California; U.S.A |
Business Address | 1781 Flight Way, |
Sector | Diversified REITs |
Industry | Real Estate |
Benchmark | Dow Jones Industrial |
Website | www.sabrahealth.com |
Phone | 888 393 8248 |
Currency | USD - US Dollar |
Sabra Healthcare Key Financial Ratios
Return On Equity | 0.0346 | ||||
Profit Margin | 0.14 % | ||||
Operating Margin | 0.36 % | ||||
Price To Sales | 6.52 X | ||||
Revenue | 655.85 M |
Sabra Healthcare Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.1B | 6.0B | 6.0B | 5.7B | 5.4B | 4.2B | |
Other Current Liab | (1.2B) | (1.2B) | (1.8B) | (197.0M) | 1.5B | 1.6B | |
Net Debt | 2.4B | 2.3B | 2.3B | 2.7B | 2.4B | 1.9B | |
Retained Earnings | (573.3M) | (716.2M) | (1.1B) | (1.5B) | (1.7B) | (1.6B) | |
Accounts Payable | 108.8M | 146.3M | 143.0M | 142.3M | 73.8M | 76.6M | |
Cash | 39.1M | 59.1M | 112.0M | 49.3M | 41.3M | 39.2M | |
Other Assets | 19M | 5.7B | 5.3B | 398.9M | 5.1B | 5.4B | |
Long Term Debt | 113.1M | 2.4B | 2.4B | 2.3B | 2.3B | 2.4B | |
Total Liab | 2.6B | 2.6B | 2.6B | 2.7B | 2.6B | 2.0B | |
Total Current Assets | 307.0M | 329.0M | 653.1M | 613.2M | 212.7M | 387.9M | |
Common Stock | 2.1M | 2.1M | 2.3M | 2.3M | 2.3M | 1.4M | |
Good Will | 167.1M | 131.1M | 101.5M | 82.8M | 95.2M | 53.1M | |
Other Current Assets | (49.1M) | (65.5M) | (115.9M) | (411.4M) | 68.1M | 71.5M | |
Intangible Assets | 101.5M | 82.8M | 54.1M | 40.1M | 30.9M | 59.5M | |
Net Tangible Assets | 3.5B | 3.4B | 3.3B | 3.0B | 3.5B | 2.4B | |
Net Receivables | 257.8M | 263.5M | 537.2M | 147.9M | 103.3M | 98.1M | |
Long Term Debt Total | 113.1M | 2.4B | 2.4B | 2.3B | 2.7B | 2.8B | |
Capital Surpluse | 4.1B | 4.2B | 4.5B | 4.5B | 5.2B | 2.9B |
Sabra Healthcare Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 126.6M | 100.4M | 98.6M | 105.5M | 113.0M | 83.2M | |
Total Revenue | 661.7M | 598.6M | 569.5M | 624.8M | 655.8M | 404.9M | |
Gross Profit | 553.3M | 467.0M | 428.3M | 462.2M | 277.5M | 326.2M | |
Operating Income | 335.3M | 241.2M | 19.0M | 135.6M | 218.6M | 163.0M | |
Ebit | 516.7M | 47.5M | (192.5M) | (52.1M) | 235.1M | 163.3M | |
Ebitda | 516.9M | 418.0M | 166.2M | 323.4M | 418.2M | 280.2M | |
Income Before Tax | 72.4M | 139.1M | (111.4M) | (76.4M) | 15.8M | 15.0M | |
Net Income | 69.0M | 138.4M | (113.3M) | (77.6M) | 13.8M | 13.1M | |
Income Tax Expense | 3.4M | 710K | 1.8M | 1.2M | 2.0M | 1.9M | |
Research Development | 0.12 | 0.24 | 0.18 | 0.14 | 0.01 | 0.0095 | |
Cost Of Revenue | 108.5M | 131.6M | 141.2M | 162.6M | 378.3M | 397.2M | |
Non Recurring | (123.5M) | (5.9M) | 13.4M | 94.2M | 108.3M | 113.7M | |
Tax Provision | 3.4M | 710K | 1.8M | 1.2M | 2.0M | 1.8M | |
Net Interest Income | (126.6M) | (100.4M) | (98.6M) | (105.5M) | (113.0M) | (118.6M) |
Sabra Healthcare Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (10.5M) | 16.4M | 50.4M | (62.0M) | (7.2M) | (6.9M) | |
Free Cash Flow | 372.5M | 249.3M | 322.8M | 315.7M | 300.6M | 169.7M | |
Depreciation | 181.5M | 176.7M | 179.0M | 187.8M | 183.1M | 116.9M | |
Other Non Cash Items | (22.2M) | 1.6M | 32.2M | 217.8M | 98.5M | 103.5M | |
Capital Expenditures | 252.5M | 105.6M | 33.6M | 146.7M | 5.2M | 5.0M | |
End Period Cash Flow | 49.1M | 65.5M | 115.9M | 53.9M | 46.7M | 89.7M | |
Dividends Paid | 335.4M | 278.3M | 262.9M | 277.2M | 277.4M | 202.1M | |
Net Income | 69.0M | 138.4M | (113.3M) | (77.6M) | 13.8M | 13.1M | |
Investments | 13.1M | 3.7M | (287.1M) | (161.5M) | 103.1M | 108.3M | |
Net Borrowings | (624M) | (3.9M) | (15.7M) | 122.8M | 110.5M | 116.0M | |
Change To Netincome | 165.4M | 38.5M | 233.8M | 212.0M | 243.8M | 256.0M |
Sabra Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sabra Healthcare's current stock value. Our valuation model uses many indicators to compare Sabra Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sabra Healthcare competition to find correlations between indicators driving Sabra Healthcare's intrinsic value. More Info.Sabra Healthcare REIT is rated below average in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about 0.82 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sabra Healthcare REIT is roughly 1.22 . At present, Sabra Healthcare's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sabra Healthcare's earnings, one of the primary drivers of an investment's value.Sabra Healthcare REIT Systematic Risk
Sabra Healthcare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sabra Healthcare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Sabra Healthcare REIT correlated with the market. If Beta is less than 0 Sabra Healthcare generally moves in the opposite direction as compared to the market. If Sabra Healthcare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sabra Healthcare REIT is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sabra Healthcare is generally in the same direction as the market. If Beta > 1 Sabra Healthcare moves generally in the same direction as, but more than the movement of the benchmark.
Sabra Healthcare Thematic Clasifications
Sabra Healthcare REIT is part of Investing investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Money and asset management including investment banking. Companies involved in money management and investment banking services
This theme covers Money and asset management including investment banking. Companies involved in money management and investment banking services. Get More Thematic Ideas
Investing | View |
Today, most investors in Sabra Healthcare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sabra Healthcare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sabra Healthcare growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Sabra Healthcare November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sabra Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sabra Healthcare REIT. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sabra Healthcare REIT based on widely used predictive technical indicators. In general, we focus on analyzing Sabra Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sabra Healthcare's daily price indicators and compare them against related drivers.
Downside Deviation | 1.8 | |||
Information Ratio | 0.0668 | |||
Maximum Drawdown | 8.78 | |||
Value At Risk | (2.50) | |||
Potential Upside | 2.51 |
Complementary Tools for Sabra Stock analysis
When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |